Award
National Institute on Aging 11262148
Democratizing Early Detection and Longitudinal Monitoring of Alzheimer's Disease: An Ultra-Sensitive Blood-Based Assay
Recipient
Redwood Neuro Inc.
Award Amount
$506,061.00
Ceiling
$506,061.00
Awarded
September 15, 2025
Identifier
11262148
Award to develop an ultra-sensitive blood-based assay platform for early detection and monitoring of Alzheimer's disease, funded by NIH with a focus on public health impact.
Description
The project aims to develop the SiMoLiSA platform for early detection of Alzheimer's disease, focusing on sensitivity, affordability, and accessibility. It involves establishing a 7-biomarker panel and validating it with clinical samples. The project emphasizes public health impact by enabling earlier diagnosis and reducing healthcare costs.